%PDF-1.4
%
1 0 obj
<>stream
iText 4.2.0 by 1T3XT2019-05-07T12:26:54+05:30Arbortext Advanced Print Publisher2020-03-22T23:52:30-07:002020-03-22T23:52:30-07:00uuid:8addd02c-2a8d-4824-a074-0375b52bef83uuid:9735c38c-787b-4f5b-aca7-e8422204bc96JournalGynecological Endocrinology© 2019 Informa UK Limited, trading as Taylor & Francis Group0951-35901473-0766356463-46946346910.1080/09513590.2019.1576616https://doi.org/10.1080/09513590.2019.1576616application/pdf10.1080/09513590.2019.1576616en-USPotential roles of carnitine in patients with polycystic ovary syndrome: a systematic reviewTaylor & FrancisGynecological Endocrinology, 2019. doi: 10.1080/09513590.2019.1576616Maleki VahidJafari-Vayghan HamedKashani ArvinMoradi FardinVajdi MahdiKheirouri SorayyaAlizadeh MohammadCarnitinepolycystic ovary syndromeglycemic statusoxidative stressVoR2019-02-26truewww.tandfonline.com10.1080/09513590.2019.1576616www.tandfonline.comtrue2019-02-2610.1080/09513590.2019.1576616
endstream
endobj
4 0 obj
<>stream
xYKo7"R=zg]zzjH/%%RN03zQ|~"O`}ïut(` `R6g8?<,)XXʒ>R\6OݷΡsY=
B44z}<]ǀ3u@hXJIhj^o¶FSO]Ou),#,9c0?~wz͠vJYpOs#v L FFoMf4¢@X7/UɆ1ǪAHlsZ&v/nf5ut@#*=o3bb|xy8l(